Epidemiology and prevention of cutaneous melanoma.

Current Treatment Options in Oncology
Marie-France Demierre

Abstract

Melanoma incidence has continued to increase in all white populations, and mortality from melanoma remains high in older men worldwide. In Australia, Europe, and the United States, a substantial number of thick melanomas in older men are of the nodular subtype, a subtype lacking asymmetry or color change. Educating the public and professionals about the significance of evolving pigmented lesions as emphasized in the revised ABCDE of pigmented lesions is relevant. Targeting screening efforts toward older men will be necessary to decrease worldwide melanoma mortality. Among prevention strategies, emphasizing multiple methods of sun protection in early childhood, adolescence, and adulthood is needed to decrease sunburn rates. Chemoprevention research in melanoma should become a research priority to complement ongoing prevention strategies.

References

May 1, 1989·The Journal of Clinical Endocrinology and Metabolism·A R WebbM F Holick
Apr 15, 1985·International Journal of Cancer. Journal International Du Cancer·J M ElwoodJ C Pearson
Dec 1, 1993·Melanoma Research·B K Armstrong, A Kricker
Aug 1, 1997·Journal of the American Academy of Dermatology·J K RobinsonR A Amonette
Jun 24, 2000·JAMA : the Journal of the American Medical Association·R P GallagherA J Coldman
Sep 6, 2000·The British Journal of Dermatology·B LindelöfR S Stern
May 3, 2001·Journal of the National Cancer Institute·A JemalM A Tucker
Aug 14, 2001·American Journal of Human Genetics·P A van der VeldenN A Gruis
May 22, 2002·Archives of Dermatology·Alexander J ChamberlainJohn W Kelly
Oct 9, 2002·JAMA : the Journal of the American Medical Association·Alan C GellerHoward K Koh
Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marie-France Demierre, Larry Nathanson
May 8, 2003·Photochemistry and Photobiology·Dianne E GodarJan C van der Leun
Jun 5, 2003·Journal of the National Cancer Institute·David C WhitemanAdèle C Green
Jun 6, 2003·Oncogene·Margaret A Tucker, Alisa M Goldstein
Jun 6, 2003·Oncogene·Chamelli JhappanGlenn Merlino
Jun 27, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E de VriesUNKNOWN Working Group of Regional Cancer Registries
Oct 24, 2003·Clinics in Dermatology·Mona Almahroos, Amal K Kurban
Mar 5, 2004·The British Journal of Dermatology·M B Lens, M Dawes
Jul 21, 2004·Archives of Dermatology·Shasa HuRobert S Kirsner
Aug 12, 2004·Melanoma Research·Cristina BosettiFabio Levi
Aug 18, 2004·Archives of Dermatology·Lori Steinberg BenjesAlan C Geller
Dec 9, 2004·JAMA : the Journal of the American Medical Association·Naheed R AbbasiDavid Polsky
Jan 22, 2005·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Feb 3, 2005·Journal of the National Cancer Institute·Kathleen M EganWilliam J Blot
Feb 3, 2005·Journal of the National Cancer Institute·Marianne BerwickRaymond Barnhill
Feb 19, 2005·Critical Reviews in Oncology/hematology·Marie-France Demierre, Vernon K Sondak
Apr 29, 2005·Journal of the American Academy of Dermatology·Henry W LimStephen P Stone
May 13, 2005·The British Journal of Dermatology·A CayuelaJ S Conejo-Mir
Jun 22, 2005·Archives of Dermatology·Marie-France DemierreAlan C Geller
Jul 22, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John J StrouseAlan S Wayne
Aug 10, 2005·The British Journal of Dermatology·B L Diffey
Sep 28, 2005·The Journal of Investigative Dermatology·Susan M SwetterJeff D Harvell
Sep 28, 2005·Cancer·Christopher S HollenbeakEugene J Lengerich
Oct 6, 2005·Journal of the National Cancer Institute·Brenda K EdwardsLinda W Pickle
Nov 1, 2005·Cancer Control : Journal of the Moffitt Cancer Center·Marie F Demierre, Vernon K Sondak
Nov 18, 2005·The New England Journal of Medicine·John A CurtinBoris C Bastian
Dec 13, 2005·Nature Reviews. Cancer·Marie-France DemierreScott M Lippman

❮ Previous
Next ❯

Citations

Feb 15, 2008·Cancer Causes & Control : CCC·Kerri M Clough-GorrMarc S Ernstoff
Jul 3, 2010·Cell Death and Differentiation·T BottonS Rocchi
Oct 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Murray A CotterDouglas Grossman
Aug 4, 2006·International Journal of Health Geographics·Laurie M DeChello, T Joseph Sheehan
May 14, 2009·Journal of Foot and Ankle Research·Ivan R Bristow, Jonathan Bowling
Dec 21, 2007·AJR. American Journal of Roentgenology·Karun V SharmaDaniel B Brown
Jun 6, 2009·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Lucie PeuvrelBrigitte Dreno
Jan 30, 2009·The Journal of Investigative Dermatology·Thomas BottonStephane Rocchi
Mar 29, 2008·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Peter HensenThomas A Luger
Aug 5, 2010·International Journal of Occupational Medicine and Environmental Health·Andrzej Marcinkiewicz, Dorota Szosland
Sep 7, 2018·Frontiers in Endocrinology·Emilie Jaune, Stéphane Rocchi
May 20, 2020·Frontiers in Endocrinology·Ziquan Lv, Yajie Guo
Jun 7, 2013·Molecular Cancer Therapeutics·Michaël CerezoStéphane Rocchi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.